J Shamash
Overview
Explore the profile of J Shamash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
407
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Powles T, Chowdhury S, Shamash J, Bazeos A, Gillessen S, Saunders N, et al.
Ann Oncol
. 2010 Oct;
22(4):815-820.
PMID: 20943595
Background: Haematopoietic progenitor cells (HPCs) are present in blood in metastatic renal cell cancer (mRCC). We investigate their expression in mRCC patients treated with sunitinib and correlate their expression with...
12.
Matakidou A, Mutsvangwa K, Ansell W, Lim L, Powles T, Oliver R, et al.
Ann Oncol
. 2010 Jun;
21(8):1730-1731.
PMID: 20530199
No abstract available.
13.
Gillessen S, Powles T, Lim L, Wilson P, Shamash J
Ann Oncol
. 2010 Feb;
21(8):1589-1593.
PMID: 20164149
Background: In some institutions advanced metastatic germ-cell tumour (GCT) is treated with low-dose induction chemotherapy in specific settings. There is a lack of published data supporting its use. The data...
14.
Murugaesu N, Powles T, Bestwick J, Oliver R, Shamash J
Osteoporos Int
. 2008 Nov;
20(9):1627-30.
PMID: 19030945
Unlabelled: Most patients with testis cancer are cured with treatment. However, the incidence of osteoporosis after prolonged follow-up is unknown. This study investigates the incidence of osteoporosis in 39 testis...
15.
Shamash J, Davies A, Ansell W, McFaul S, Wilson P, Oliver T, et al.
Br J Cancer
. 2008 Jan;
98(1):22-4.
PMID: 18182976
When chemotherapy is used in androgen-independent prostate cancer (AIPC), androgen deprivation is continued despite its failure. In this study, we investigated whether it was possible to re-induce hormone sensitivity in...
16.
Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T
Ann Oncol
. 2007 Dec;
19(3):443-7.
PMID: 18048383
Background: The use of adjuvant carboplatin in the management of stage I seminoma of the testis has been limited by the lack of long-term data. In this study, we address...
17.
Berney D, Warren A, Verma M, Kudahetti S, Robson J, Williams M, et al.
Mod Pathol
. 2007 Nov;
21(1):54-9.
PMID: 17975539
Malignant testicular germ cell tumours in the elderly are extremely rare with anecdotal accounts of their aggressive behaviour. Fifty cases of germ cell tumour, diagnosed at the age of 60...
18.
Shamash J, Powles T, Ansell W, Berney D, Stebbing J, Mutsvangwa K, et al.
Br J Cancer
. 2007 Jul;
97(3):308-14.
PMID: 17609665
There is no consensus as to the management of untreated poor prognosis or relapsed/refractory germ cell tumours. We have studied an intensive cisplatin-based regimen that incorporates high-dose methotrexate (HD MTX)...
19.
Shamash J, Powles T, Mutsvangwa K, Wilson P, Ansell W, Walsh E, et al.
Ann Oncol
. 2007 Mar;
18(5):925-30.
PMID: 17355956
Background: The outcome of patients with germ-cell tumours (GCTs), who relapse more than once or relapse with a mediastinal primary is poor. We have shown that topoisomerase 1 may be...
20.
Shamash J, Dancey G, Barlow C, Wilson P, Ansell W, Oliver R
Br J Cancer
. 2004 Dec;
92(1):36-40.
PMID: 15570307
The management of androgen independent prostate cancer is increasingly disputed. Diethylstilbestrol and steroids have useful second-line activity in its management. The value of chemotherapy still remains contentious. This paper reports...